A probable early driver of Alzheimer's disease is the accumulation of molecules called amyloid peptides. These cause cell death, and are commonly found in the brains of Alzheimer’s patients. Researchers at Chalmers University of Technology, have now shown that yeast cells that accumulate these misfolded amyloid peptides can recover after being treated with graphene oxide nanoflakes.
While the approach has only been tested in yeast models of human brain cells, it could pave the way to a new clinical therapy for the progressive neurological disease.
Graphene oxide nanoflakes reduce the toxicity of Alzheimer s proteins, shows study phys.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phys.org Daily Mail and Mail on Sunday newspapers.